Page last updated: 2024-09-04

moxifloxacin and Corneal Ulcer

moxifloxacin has been researched along with Corneal Ulcer in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (33.33)	29.6817
2010's	41 (56.94)	24.3611
2020's	7 (9.72)	2.80

Authors

Authors	Studies
Durrani, A; Jhanji, V; Kowalski, RP; Verner, A	1
Sowka, J; Vollmer, L	1
Galor, A; Huang, AM; Quan, AV	1
Atta, S; Bhat, AK; Dhaliwal, D; Durrani, AF; Jhanji, V; Kowalski, RP; Mammen, A	1
Graue-Hernandez, EO; Lichtinger, A; Navas, A; Polania-Baron, EJ; Santana-Cruz, O	1
Austin, AF; Keenan, JD; Lalitha, P; Lietman, TM; Liu, Z; Narayana, S; Porco, TC; Prajna, NV; Radhakrishnan, N; Rajaraman, R; Rose-Nussbaumer, J	1
Chodosh, J; Ma, KK; Saeed, HN; Tone, SO	1
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC	1
Galvis, V; Gómez, MA; Grice, JM; Niño, CA; Tello, A	1
Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ	1
Acharya, NR; Borkar, DS; Fleiszig, SM; Ghanekar, AA; Lalitha, P; Leong, C; Li, WY; Lietman, TM; McLeod, SD; Srinivasan, M; Tam, C; Zegans, ME	1
Agarwal, P; Bansal, S; Goel, M; Sharma, N; Titiyal, JS; Upadhyaya, AD; Vajpayee, RB	1
Acharya, NR; Borkar, DS; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME	1
Ohashi, Y; Suzuki, T	1
Kalavathy, CM; Kaliamurthy, J; Nelson Jesudasan, CA; Parmar, P; Thomas, PA	1
de la Jara, PL; Holden, BA; Naduvilath, T; Ozkan, J; Rathi, VM; Srikanth, D; Willcox, MD; Zhu, H	1
Acharya, NR; Glidden, DV; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Whitcher, JP; Zegans, ME	1
Binder, PS; Kontadakis, GA; Kymionis, GD; Pallikaris, IG; Plaka, AD; Tsoulnaras, KI	1
Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME	1
Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; McClintic, SM; O'Brien, KS; Oldenburg, CE; Prajna, NV; Rajaraman, R; Ray, KJ; Srinivasan, M	1
Estrela, C; Puente, CG; Regalado Farreras, DC	1
Farahat, HG; Mandour, SS; Marey, HM	1
Baviera, J; Beltran, J; Djodeyre, MR; Llovet-Osuna, F; Llovet-Rausell, A; Ortega-Usobiaga, J	1
Akyar, I; Celik, E; Cosar, CB; Gonen, T; Ince, U; Kucuk, M; Serteser, M; Tokat, F	1
Bharti, SK; Kesavan, K	1
Barrett, R; Lehmann, AE; Matoba, AY	1
Eisen, L; Kim, J; Rosenberg, J	1
Giannoni, AG; Miller, WL; Perrigin, J	1
Farley, SJ; Mack, RJ; Schatz, S; Shott, S	1
Berkner, L; Hazarbassanov, R; Michaeli, A; Regenbogen, M; Varssano, D; Waisbourd, M	1
Betanzos-Cabrera, G; Cancino-Díaz, JC; Cancino-Díaz, ME; González-González, G; Juárez-Verdayes, MA	1
Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Shafiee, A	2
Pacheco, PA; Tam, PM	1
Agarwal, T; Chawla, B; Nayak, N; Satpathy, G; Shah, VM; Sharma, N; Tandon, R; Titiyal, JS; Vajpayee, RB	1
Huang, FC; Shih, MH	1
Hesje, CK; Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Sanfilippo, CM; Shafiee, A	1
Carlson, EM; Meskin, SW	1
Bansal, S; Sachdev, R; Sharma, N; Sinha, R; Titiyal, JS	1
Girgis, DO; Karp, CL; Miller, D	1
Acharya, NR; Glidden, DV; Hong, KC; Lalitha, P; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME	2
Acharya, NR; Glidden, D; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME	1
Acharya, NR; Bharathi, MJ; Cevallos, V; Glidden, DV; Lalitha, P; Lietman, TM; Manikandan, P; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Toutain-Kidd, CM; Zegans, ME	1
Matoba, AY	1
Acharya, NR; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Priya, JL; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME	1
Banerjee, P; Biswas, S; Chattopadhyay, C; Das, D; Mondal, KK; Ray, B	1
Bosjolie, A; Qiao, M; Shih, CY; Udell, IJ	1
Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM	1
Agarwal, T; Chawla, B; Jhanji, V; Nayak, N; Satpathy, G; Tandon, R; Titiyal, JS	1
Acharya, NR; Esterberg, EJ; Glaser, TS; Lietman, TM; McLeod, SD; Oldenburg, CE; Ray, KJ; Saravanan, S; See, CW; Srinivasan, M; Tu, EY; Zegans, ME	1
Acharya, NR; Greninger, DA; Keenan, JD; Lietman, TM; Mascarenhas, J; McClintic, SM; Srinivasan, M	1
Acharya, NR; Geetha, M; Glidden, D; Karpagam, R; Lietman, TM; McLeod, SD; Oldenburg, CE; Prajna, L; Ray, KJ; Srinivasan, M; Sun, CQ	1
Acharya, NR; Bharathi, MJ; Glidden, DV; Lalitha, P; Lietman, TM; Manikandan, P; Mascarenhas, J; Nardone, N; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M	1
Dhaliwal, DK; Gordon, YJ; Karenchak, LM; Kowalski, RP; Mah, FS; Ritterband, DC; Romanowski, EG	1
Curtis, MA; Dahlin, DC; Dembinska, O; Liao, J; Owen, GR; Robertson, SM; Rusinko, A; Schlech, BA	1
Holt, WF; Kastner, PR; McGee, DH; Rice, RL	1
Cupp, GA; Dajcs, JJ; Schlech, BA; Stroman, DW	1
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN	1
Caballero, AR; Dajcs, JJ; Johnston, KH; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA	1
Feiz, V; Kang, PC; Mirzaian, G; Moshirfar, M	1
Tyler, ME; Walter, K	1
McAllum, P; Poutanen, SM; Slomovic, AR; Srinivasan, S	1
Alfonso, EC; Karp, CL; Miller, D; Munir, WM; Rosenfeld, SI; Udell, I	1
Jhanji, V; Satpathy, G; Sharma, N; Titiyal, J	1
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT	1
Mamalis, N	1
Espandar, L; Meyer, JJ; Moshirfar, M	1
Delgado, J; Diaz, LA; Galvis, V; Gómez, AJ; Tello, A; Valencia, F	1
Acharya, NR; Chen, A; Lietman, TM; Mahalakshmi, R; McLeod, S; Prajna, L; Srinivasan, M; Whitcher, JP	1
Balzli, CL; Caballero, AR; Huang, B; McCormick, CC; O'Callaghan, RJ; Smith, E; Tang, A; Wigington, L	1
Borderie, V; Bourcier, T; Dupas, B; Laroche, L; Maftouhi, AE; Puech, M; Semoun, O	1

Reviews

7 review(s) available for moxifloxacin and Corneal Ulcer

Article	Year
A Case of Nocardia farcinica Keratitis in a Pediatric Contact Lens Wearer. Eye & contact lens, 2020, Volume: 46, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Bacterial; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Visual Acuity	2020
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma. Archivos de la Sociedad Espanola de Oftalmologia, 2019, Volume: 94, Issue:2 Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Combined Modality Therapy; Contact Lenses, Hydrophilic; Corneal Ulcer; Facial Nerve Injuries; Facial Paralysis; Female; Humans; Insulin; Keratitis; Middle Aged; Moxifloxacin; Neuroma, Acoustic; Postoperative Complications; Staphylococcal Infections; Trigeminal Nerve Injuries; Vancomycin	2019
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. Journal of refractive surgery (Thorofare, N.J. : 1995), 2018, Sep-01, Volume: 34, Issue:9 Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult	2018
Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. Ocular immunology and inflammation, 2011, Volume: 19, Issue:5 Topics: Amnion; Antibodies, Monoclonal; Aza Compounds; Conjunctiva; Corneal Perforation; Corneal Ulcer; Dermatologic Agents; Disease Progression; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Moxifloxacin; Prednisolone; Prednisone; Quinolines; Severity of Illness Index; Treatment Outcome; Visual Acuity	2011
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Survey of ophthalmology, 2005, Volume: 50 Suppl 1 Topics: Administration, Topical; Animals; Aqueous Humor; Aza Compounds; Biological Availability; Cell Line; Cell Membrane Permeability; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ophthalmic Solutions; Quinolines; Tears; Vitreous Body	2005
Safety of moxifloxacin as shown in animal and in vitro studies. Survey of ophthalmology, 2005, Volume: 50 Suppl 1 Topics: Animals; Aza Compounds; Bacteria; Corneal Ulcer; Epithelium, Corneal; Eye Infections, Bacterial; Fluoroquinolones; Moxifloxacin; Ophthalmic Solutions; Quinolines; Wound Healing	2005
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Survey of ophthalmology, 2005, Volume: 50 Suppl 1 Topics: Administration, Topical; Animals; Aza Compounds; Bacteria; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Microbial; Eye Infections, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines	2005

Trials

17 trial(s) available for moxifloxacin and Corneal Ulcer

Article	Year
Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis. Cornea, 2021, Jul-01, Volume: 40, Issue:7 Topics: Aged; Anti-Bacterial Agents; Bacteria; Collagen; Combined Modality Therapy; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Moxifloxacin; Photochemotherapy; Photosensitizing Agents; Riboflavin; Treatment Outcome; Ultraviolet Rays; Visual Acuity	2021
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Ophthalmology, 2013, Volume: 120, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prevalence; Prospective Studies; Quinolines; Therapeutic Equivalency; Tobramycin; Treatment Outcome; Visual Acuity	2013
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic epidemiology, 2013, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Aza Compounds; Communicable Diseases, Emerging; Cornea; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines	2013
Effect of antibiotic drops on adverse events during extended lens wear. Optometry and vision science : official publication of the American Academy of Optometry, 2014, Volume: 91, Issue:1 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Contact Lenses, Extended-Wear; Corneal Ulcer; Equipment Contamination; Eye Infections, Bacterial; Eyelids; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Hydrogels; Male; Microbiota; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Quinolines; Silicones; Young Adult	2014
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. American journal of ophthalmology, 2014, Volume: 157, Issue:2 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity	2014
Visual recovery in treated bacterial keratitis. Ophthalmology, 2014, Volume: 121, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Recovery of Function; Visual Acuity	2014
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up. Investigative ophthalmology & visual science, 2014, May-02, Volume: 55, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Prospective Studies; Quinolines; Regression Analysis; Visual Acuity	2014
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea, 2010, Volume: 29, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome; Visual Acuity; Young Adult	2010
The steroids for corneal ulcers trial: study design and baseline characteristics. Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:2 Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Research Design; Treatment Outcome; Visual Acuity	2012
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:2 Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity	2012
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative ophthalmology & visual science, 2012, Jan-25, Volume: 53, Issue:1 Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Outcome; Visual Acuity	2012
Nocardia keratitis: clinical course and effect of corticosteroids. American journal of ophthalmology, 2012, Volume: 154, Issue:6 Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Polymerase Chain Reaction; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity	2012
Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic epidemiology, 2012, Volume: 19, Issue:6 Topics: Administration, Topical; Anti-Infective Agents; Aza Compounds; Bayes Theorem; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Surveys and Questionnaires; Treatment Outcome; Visual Acuity	2012
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA ophthalmology, 2013, Volume: 131, Issue:3 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Pneumococcal Infections; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae	2013
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative ophthalmology & visual science, 2013, Feb-28, Volume: 54, Issue:2 Topics: Administration, Topical; Anti-Infective Agents; Aza Compounds; Bacteria; Corneal Ulcer; Disease Susceptibility; Double-Blind Method; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity	2013
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology, 2007, Volume: 114, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome	2007
Does in vitro susceptibility predict clinical outcome in bacterial keratitis? American journal of ophthalmology, 2008, Volume: 145, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Corneal Ulcer; Disease Susceptibility; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Pilot Projects; Prednisolone; Quinolines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Visual Acuity	2008

Other Studies

48 other study(ies) available for moxifloxacin and Corneal Ulcer

Article	Year
Case Report: Corneal Ulceration from Bilateral Ectropion Due to Congenital Ichthyosis. Optometry and vision science : official publication of the American Academy of Optometry, 2019, Volume: 96, Issue:9 Topics: Adult; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Ectropion; Female; Humans; Ichthyosis, Lamellar; Moxifloxacin; Parasympatholytics; Polymyxin B; Slit Lamp Microscopy; Trimethoprim; Tropanes	2019
Ciprofloxacin Corneal Deposits With Complete Dissipation After Switching to Moxifloxacin. JAMA ophthalmology, 2020, 03-01, Volume: 138, Issue:3 Topics: Administration, Ophthalmic; Aged; Anti-Bacterial Agents; Chemical Precipitation; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Substitution; Eye Infections, Bacterial; Humans; Male; Moxifloxacin; Ophthalmic Solutions; Pseudomonas Infections; Slit Lamp Microscopy	2020
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes. American journal of ophthalmology, 2020, Volume: 214 Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Combinations; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vancomycin	2020
Treatment of Severe Infectious Keratitis With Scleral Contact Lenses as a Reservoir of Moxifloxacin 0.5. Cornea, 2021, Jul-01, Volume: 40, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspergillosis; Contact Lenses; Corneal Ulcer; Drug Carriers; Escherichia coli Infections; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pseudomonas Infections; Sclera; Staphylococcal Infections; Visual Acuity; Young Adult	2021
Ochrobactrum anthropi Keratitis in a Boston Type 1 Keratoprosthesis Recipient. Cornea, 2021, May-01, Volume: 40, Issue:5 Topics: Aged; Anti-Bacterial Agents; Artificial Organs; Ceftazidime; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Moxifloxacin; Ochrobactrum anthropi; Prostheses and Implants; Slit Lamp Microscopy; Visual Acuity	2021
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes. Scientific reports, 2021, 03-18, Volume: 11, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy	2021
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA ophthalmology, 2013, Volume: 131, Issue:2 Topics: Anti-Infective Agents; Aza Compounds; Bacterial Toxins; Bacterial Typing Techniques; Corneal Ulcer; DNA, Bacterial; Exotoxins; Eye Infections, Bacterial; Fluoroquinolones; Genotype; Glucocorticoids; Humans; L-Lactate Dehydrogenase; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Virulence; Visual Acuity	2013
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index. Cornea, 2013, Volume: 32, Issue:7 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin	2013
Spectrum of bacterial keratitis at a tertiary eye care centre in India. BioMed research international, 2013, Volume: 2013 Topics: Aza Compounds; Ciprofloxacin; Corneal Ulcer; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus	2013
Femtosecond Laser-Assisted Intra-Corneal Drug Delivery. Seminars in ophthalmology, 2015, Volume: 30, Issue:5-6 Topics: Abscess; Aged; Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Surgery, Laser; Corneal Ulcer; Drug Delivery Systems; Drug Implants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Lasers, Excimer; Moxifloxacin; Voriconazole	2015
Sodium hypochlorite chemical burn in an endodontist's eye during canal treatment using operating microscope. Journal of endodontics, 2014, Volume: 40, Issue:8 Topics: Accidents, Occupational; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents; Burns, Chemical; Corneal Ulcer; Cyclopentolate; Dentists; Eye Burns; Female; Fluoroquinolones; Follow-Up Studies; Humans; Ibuprofen; Loteprednol Etabonate; Microsurgery; Moxifloxacin; Mydriatics; Occupational Diseases; Prednisolone; Root Canal Irrigants; Root Canal Preparation; Sodium Hypochlorite; Therapeutic Irrigation; Young Adult	2014
Resistant Microbial Keratitis in South Nile Delta, Egypt: Influence of Regional Risk Factors. Seminars in ophthalmology, 2016, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Climate; Corneal Ulcer; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Therapy, Combination; Egypt; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fluoroquinolones; Fungi; Geography; Humans; Incidence; Infant; Infant, Newborn; Ketoconazole; Male; Middle Aged; Moxifloxacin; Natamycin; Prospective Studies; Risk Factors; Social Class	2016
Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment. Journal of cataract and refractive surgery, 2015, Volume: 41, Issue:6 Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Incidence; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Moxifloxacin; Myopia; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Tobramycin; Visual Acuity; Young Adult	2015
Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits. Cornea, 2015, Volume: 34, Issue:10 Topics: Animals; Anti-Bacterial Agents; Biological Availability; Collagen; Colony Count, Microbial; Cornea; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Moxifloxacin; Photosensitizing Agents; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Riboflavin; Tissue Distribution	2015
Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis. Ocular immunology and inflammation, 2017, Volume: 25, Issue:4 Topics: Animals; Anti-Bacterial Agents; Corneal Ulcer; Drug Delivery Systems; Emulsions; Escherichia coli; Eye Infections, Bacterial; Fluoroquinolones; Hexoses; Microscopy, Electron, Transmission; Moxifloxacin; Myristates; Oils; Particle Size; Phase Transition; Polysorbates; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Water	2017
Cure Rate of Fungal Keratitis With Antibacterial Therapy. Cornea, 2017, Volume: 36, Issue:5 Topics: Adult; Anti-Bacterial Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Male; Middle Aged; Moxifloxacin	2017
Moxifloxacin for bacterial keratitis. Ophthalmology, 2008, Volume: 115, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome	2008
A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment. Contact lens & anterior eye : the journal of the British Contact Lens Association, 2008, Volume: 31, Issue:4 Topics: Adult; Anti-Infective Agents; Antifungal Agents; Aza Compounds; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Quinolines; Tobramycin	2008
Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:3 Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Drug Contamination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines	2009
Late-onset laser in situ keratomileusis-related corneal ulcer--a case series. Cornea, 2009, Volume: 28, Issue:5 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections; Surgical Flaps; Time Factors	2009
Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic research, 2009, Volume: 42, Issue:1 Topics: Anti-Infective Agents; Aza Compounds; Conjunctivitis; Corneal Ulcer; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus epidermidis	2009
Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea, 2009, Volume: 28, Issue:9 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Treatment Outcome	2009
Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:2 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Treatment Outcome	2010
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:5 Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Young Adult	2010
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Investigative ophthalmology & visual science, 2011, Jan-05, Volume: 52, Issue:1 Topics: Amikacin; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Methylene Blue; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Photochemotherapy; Quinolines; Rabbits	2011
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Cornea, 2011, Volume: 30, Issue:1 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Azepines; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Disease Susceptibility; DNA, Bacterial; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Sequence Analysis, DNA	2011
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series. Ocular immunology and inflammation, 2011, Volume: 19, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Amnion; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Aza Compounds; Benzamidines; Carboxymethylcellulose Sodium; Cefazolin; Chlorhexidine; Corneal Ulcer; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pain; Quinolines; Stevens-Johnson Syndrome; Tobramycin; Treatment Outcome; Tropanes; Visual Acuity	2011
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clinical & experimental ophthalmology, 2012, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Corneal Ulcer; Eye Infections, Bacterial; Female; Florida; Fluoroquinolones; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Quinolines; Retrospective Studies; Risk Factors; Surgical Wound Infection; Young Adult	2012
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Corneal Ulcer; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Treatment Outcome	2012
Fungal keratitis responsive to moxifloxacin monotherapy. Cornea, 2012, Volume: 31, Issue:10 Topics: Adult; Aged; Anti-Infective Agents; Ascomycota; Aspergillus; Aza Compounds; Candida; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycoses; Paecilomyces; Quinolines; Treatment Outcome; Visual Acuity; Young Adult	2012
Corneal ulcer with Scopulariopsis brevicaulis and Staphylococcus aureus--a rare case report. Journal of the Indian Medical Association, 2012, Volume: 110, Issue:4 Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections; Fluoroquinolones; Humans; Male; Moxifloxacin; Natamycin; Quinolines; Scopulariopsis; Staphylococcal Infections; Staphylococcus aureus	2012
Bilateral corneal ulceration in keratoconus. Ophthalmology, 2012, Volume: 119, Issue:10 Topics: Aza Compounds; Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Doxycycline; Drug Therapy, Combination; Electrocoagulation; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconus; Male; Middle Aged; Moxifloxacin; Photosensitizing Agents; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin	2012
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. Cornea, 2013, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin	2013
Moxifloxacin resistance: intrinsic to antibiotic or related to mutation? Optometry and vision science : official publication of the American Academy of Optometry, 2012, Volume: 89, Issue:12 Topics: Anti-Bacterial Agents; Aza Compounds; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Retrospective Studies	2012
Improvement in corneal scarring following bacterial keratitis. Eye (London, England), 2013, Volume: 27, Issue:3 Topics: Adult; Aged; Aza Compounds; Cicatrix; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pneumococcal Infections; Prednisolone; Pseudomonas Infections; Quinolines; Vision Disorders; Visual Acuity	2013
Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. American journal of ophthalmology, 2003, Volume: 136, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2003
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin	2005
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Current eye research, 2006, Volume: 31, Issue:1 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits	2006
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:3 Topics: Adult; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Lasers, Excimer; Microbial Sensitivity Tests; Moxifloxacin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Pseudomonas Infections; Quinolines; Staphylococcal Infections	2006
Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases. Cornea, 2006, Volume: 25, Issue:7 Topics: Adult; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Corneal Edema; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines	2006
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:12 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Piperacillin; Quinolines	2006
Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. Cornea, 2007, Volume: 26, Issue:5 Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Ascomycota; Aza Compounds; Cefazolin; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Ophthalmic Solutions; Quinolines; Tobramycin	2007
Fourth-generation fluoroquinolone-resistant bacterial keratitis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:8 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin	2007
The increasing problem of antibiotic resistance. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus. Cornea, 2007, Volume: 26, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Keratoconus; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin	2007
Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:2 Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratomileusis, Laser In Situ; Methicillin Resistance; Moxifloxacin; Postoperative Complications; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps	2008
Early bacterial keratitis after presbyopic LASIK. Cornea, 2008, Volume: 27, Issue:1 Topics: Administration, Oral; Administration, Topical; Anti-Infective Agents, Local; Aza Compounds; Bacitracin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Keratomileusis, Laser In Situ; Microscopy, Confocal; Middle Aged; Moxifloxacin; Pain, Postoperative; Presbyopia; Propionibacterium acnes; Quinolines; Visual Acuity	2008